Condition: Ulcerative Colitis · Crohn's Disease · Sponsor: Takeda
The main aim of this study is to learn how the body of a child or teenager with moderately to severely active ulcerative colitis (UC) or Crohn's disease (CD) processes vedolizumab (pharmacokinetics) given just under the skin subcutaneously (SC). The participants will be treated with vedolizumab for up to 34 weeks. During the study, participants will visit their study clinic several times.
This description comes directly from the study's public registry record.
Takeda Contact · +1-877-825-3327 · medinfoUS@takeda.com
Always discuss trial participation with your own doctor first.
| Phoenix Children's Hospital | Phoenix, Arizona, United States | Not Yet Recruiting |
| Loma Linda University School of Medicine | Loma Linda, California, United States | Active Not Recruiting |
| Children's Hospital Of Orange County | Orange, California, United States | Recruiting |
| Stanford Children's Health | Palo Alto, California, United States | Active Not Recruiting |
| Advocate Children's Hospital | Park Ridge, Illinois, United States | Active Not Recruiting |
| Children's Hospital of Michigan | Detroit, Michigan, United States | Recruiting |
| Atlantic Health System | Morristown, New Jersey, United States | Active Not Recruiting |
| New York Presbyterian Hospital, Weill Cornell Medical College | New York, New York, United States | Active Not Recruiting |
| University Hospitals Cleveland Medical Center | Cleveland, Ohio, United States | Active Not Recruiting |
| Cleveland Clinic Foundation | Cleveland, Ohio, United States | Active Not Recruiting |
| The University of Oklahoma Health Sciences Center | Oklahoma City, Oklahoma, United States | Recruiting |
| Penn State Health Milton S. Hershey Medical Center/ Penn State University College of Medicine | Hershey, Pennsylvania, United States | Active Not Recruiting |
+ 42 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06100289